Not checkedNot checked for notices yet.
Drug-Induced Liver Injury by Glatiramer Acetate Used for Treatment of Multiple Sclerosis
Attila Onmez, Ahmet Tarik Eminler, Hasan Ergenç and 3 more
Journal of Investigative Medicine High Impact Case Reports · 2013
doi:10.1177/2324709613517493 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Glatiramer acetate (GA, Copaxone) is an approved drug for the treatment of relapsing–remitting multiple sclerosis. Most common side effects observed with GA are local injection site reactions, which can include pain, swelling, or redness. However, systemic adverse event such as hepatotoxicity related to GA is rarely seen. In this report, we present a case of GA-induced toxic hepatitis associated with cholestatic and hepatocellular damage.
Abstract licence: CC BY
References13
13 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.